# Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.

> **NCT00141128** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Urinary Incontinence, Stress

## Interventions

- **DRUG:** SS-RBX

## Key facts

- **NCT ID:** NCT00141128
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2011-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141128, "Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00141128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*